AFT blames covid for up to 50% profit downgrade

Staff reporters
Thu, 01 Apr 2021

AFT Pharmaceuticals has downgraded its profit guidance by as much as 50% and blames that on delays to licensing negotiations, hampered by the covid pandemic.The company now expects operating profit will come in between $9 million and $11m for the year ended yesterday compared with its November guidance of $14m to $18m."We are disappointed to be revising our guidance, a move which, to a large extent, reflects delays to licensing negotiations we expected to conclude in the 2021 financial year," said founder and managing director Hartley...

Use the information you’ve already given Google to create your subscription.

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Property
Pet food millionaire snaffles Taupō racetrack
Pattrick Smellie | Sat, 17 Apr 2021

Tony Quinn is adding Taupō's Bruce McLean Park to the motorsport facilities he already owns at Hampton Downs and Highlands.

Markets Exclusive
Market regulator blasts Australian 'culture of leaks'
Dan Brunskill | Sat, 17 Apr 2021

Leaks are threatening market integrity and should not be tolerated, NZ RegCo says.

Opinion
The traditional office is dying a slow, painful death
Jehan Casinader | Sat, 17 Apr 2021

The modern workplace has been through various iterations in recent decades, but no one questioned why it existed in the first place.

Partner Content
Highlights from the New Zealand company earnings season

The February earnings season has provided a snapshot of the impact covid-19 has had on different sectors over the last six months and expectations for the year ahead.

Sponsored
Now’s the time to ask hard questions on our future land use

How can we work together to strengthen our economy and support Kiwis to prosper while protecting our natural environment and our climate.

Loading...